Analyst Reco. Centene Corporation

Stocks

CNC

US15135B1017

Managed Healthcare

Market Closed - NYSE Other stock markets 01:30:02 13/06/2026 am IST			5-day change	1st Jan Change
65.19 ^USD	+2.60%		+4.59%	+58.42%

12/06	Centene Insider Sold Shares Worth $5,164,000, According to a Recent SEC Filing	MT
10/06	Encompass Housing announced that it has received funding from HealthNet Limited, Centene Corporation	CI

Analyst Reco.

08/06	JPMorgan Adjusts Price Target on Centene to $60 From $52, Maintains Neutral Rating	MT
04/06	Morgan Stanley Raises Price Target on Centene to $57 From $50, Keeps Equalweight Rating	MT
04/06	Morgan Stanley Adjusts Price Target on Centene to $57 From $50, Maintains Equalweight Rating	MT
01/06	Truist Raises Price Target on Centene to $71 From $58, Keeps Buy Rating	MT
27/05	Oppenheimer Adjusts Centene Price Target to $67 From $58, Maintains Outperform Rating	MT
26/05	Barclays Adjusts Price Target on Centene to $75 From $63, Maintains Overweight Rating	MT
22/05	UBS Adjusts Price Target on Centene to $61 From $55, Maintains Neutral Rating	MT
21/05	BofA Securities Lifts Price Target on Centene to $72 From $60	MT
20/05	Deutsche Bank Upgrades Centene to Buy From Hold, Adjusts PT to $80 From $53	MT
20/05	Mizuho Adjusts Price Target on Centene to $58 From $50, Maintains Neutral Rating	MT
05/05	Bernstein Adjusts Price Target on Centene to $68 From $48, Maintains Outperform Rating	MT
05/05	JPMorgan Adjusts Price Target on Centene to $52 From $41, Maintains Neutral Rating	MT
01/05	Wells Fargo Adjusts Centene Price Target to $56 From $44	MT
29/04	Morgan Stanley Adjusts Price Target on Centene to $50 From $45, Maintains Equalweight Rating	MT
29/04	Mizuho Adjusts Price Target on Centene to $50 From $41, Maintains Neutral Rating	MT
29/04	Truist Raises Price Target on Centene to $58 From $49, Keeps Buy Rating	MT
29/04	Oppenheimer Adjusts Price Target on Centene to $58 From $45, Maintains Outperform Rating	MT
29/04	Deutsche Bank Adjusts Centene Price Target to $53 From $39, Maintains Hold Rating	MT
29/04	UBS Adjusts Price Target on Centene to $55 From $42, Maintains Neutral Rating	MT
29/04	Barclays Adjusts Centene Price Target to $63 From $54, Maintains Overweight Rating	MT
29/04	Jefferies Adjusts Centene Price Target to $48 From $39, Maintains Hold Rating	MT
29/04	Goldman Sachs Adjusts Centene Price Target to $40 From $32, Maintains Sell Rating	MT
29/04	Cantor Fitzgerald Upgrades Centene to Overweight From Neutral, Adjusts PT to $60 From $41	MT
20/04	Jefferies Adjusts Price Target on Centene to $39 From $37, Maintains Hold Rating	MT
15/04	Baird Adjusts Price Target on Centene to $37 From $36, Maintains Neutral Rating	MT